Aurobindo Pharma Limited (NSE:AUROPHARMA)
1,051.70
-15.70 (-1.47%)
Aug 26, 2025, 11:30 AM IST
Aurobindo Pharma Employees
Aurobindo Pharma had 27,707 employees as of March 31, 2025. The number of employees increased by 1,692 or 6.50% compared to the previous year.
Employees
27,707
Change (1Y)
1,692
Growth (1Y)
6.50%
Revenue / Employee
11.56M INR
Profits / Employee
1.22M INR
Market Cap
619.95B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 27,707 | 1,692 | 6.50% |
Mar 31, 2024 | 26,015 | 2,564 | 10.93% |
Mar 31, 2023 | 23,451 | 8,020 | 51.97% |
Mar 31, 2022 | 15,431 | -3,933 | -20.31% |
Mar 31, 2021 | 19,364 | 895 | 4.85% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 10,542 |
Cipla | 30,313 |
Apollo Hospitals Enterprise | 42,497 |
Mankind Pharma | 26,978 |
Zydus Lifesciences | 27,917 |
Fortis Healthcare | 12,237 |
Alkem Laboratories | 18,785 |
Aurobindo Pharma News
- 6 days ago - Aurobindo Pharma denies media reports on $5.5 billion Zentiva buyout - Business Upturn
- 14 days ago - Pharma sector stocks in focus: Citi flags competitive setback for Dr Reddy’s, Aurobindo in iron sucrose opportunity - Business Upturn
- 20 days ago - Raymond to Dr Reddy's: Textiles, pharma stocks bear tariffs brunt - The Times of India
- 21 days ago - Aurobindo Pharma share: Macquarie downgrades to underperform, flags US business concerns - Business Upturn
- 21 days ago - Aurobindo Pharma board declares interim dividend of Rs 4 per share for FY26 - Business Upturn
- 22 days ago - Top Q1 results today, August 4: Shree Cements, Aurobindo Pharma, DLF, Marico, Godfrey Phillips and more to announce earnings - Business Upturn
- 25 days ago - Amid Trump tariff fears, Aurobindo strikes biggest deal; To acquire Lannett for Rs 2185 crore - The Times of India
- 5 weeks ago - Amicus gains as Morgan Stanley upgrades on Aurobindo case and Pom-Op switching - Seeking Alpha